http://www.washingtonpost.com/ac2/wp-dyn/A39677-2003Aug24?language=printer


Enzymes Found to Delay Aging Process 
Discovery Could Lead to Drugs to Extend Life Span 

By Rick Weiss
Washington Post Staff Writer
Monday, August 25, 2003; Page A02 


Scientists have found for the first time a way to rev up a potent
"anti-aging" enzyme in living cells, an advance they said could speed the
development of drugs to extend human life span and prevent a wide range
of geriatric diseases.

The novel approach has significantly increased the life spans of yeast
and human cells in laboratory dishes and extended the lives of flies and
worms -- organisms that, on the level of molecular biology, age much as
humans do. Indeed, the researchers said, the compounds seem to have the
same anti-aging effect as a drastic reduction in calories, the only
strategy ever proven to extend life in mammals but one that most people
find difficult to stick to.

It is too soon to say whether the latest findings will ever make the leap
from the lab bench to the geriatrics clinic -- though some may choose not
to wait: Of all the compounds the researchers tested, the one that
boosted the anti-aging enzyme the most was resveratrol, an ingredient in
red wine that has been credited with that beverage's ability to lower the
risk of heart disease.

But the findings strengthen an increasingly popular notion among many
scientists that the cellular enzymes at the core of the experiments --
called sirtuins -- are universal regulators of aging in virtually all
living organisms and represent a prime target for new anti-aging drugs.

"It's looking like these sirtuins serve as guardians of the cell," said
Harvard Medical School researcher David Sinclair, who led the new work
published in yesterday's online edition of the journal Nature. "These
enzymes allow cells to survive damage and delay cell death."

Now the race is on, Sinclair said, to find the most potent sirtuin
stimulators -- or create synthetic ones -- and test their ability to
extend the lives not only of cells, flies and worms but also of mice,
monkeys and humans.

Other researchers were more cautious, warning that aging is a complex and
poorly understood process that is unlikely to be slowed by any single
drug. As promising as the research may appear today, they said, sirtuin
would not be the first fountain of youth to prove a mirage.

"Let's face it, aging isn't the same in humans and yeast," said Jef
Boeke, a yeast geneticist at the Johns Hopkins University School of
Medicine. Besides, he said, sirtuins are potent molecules, and in
cranking them up, "one would have to be very careful about potential side
effects." The new study caps a three-year string of discoveries involving
sirtuins (pronounced sir-TOO-ins), a class of enzymes that are found in
virtually every organism, including bacteria, plants and people. As with
all enzymes, their job is to promote essential biochemical reactions
inside cells.

At first scientists thought sirtuins spent most of their time pulling key
molecules off the proteins that surround DNA -- part of the process by
which cells turn their genes on and off.

But recently researchers learned that sirtuins are also involved in
processes with much more medical -- and commercial -- potential: They are
part of a feedback system that enhances cell survival during times of
stress, especially if that stress is a lack of food.

For years researchers have known that life span can be extended by 50
percent or more in many kinds of creatures, including flies, worms and
mice, if the animal is fed a diet that is nutritious but contains about
30 percent fewer calories than usual. Recently scientists found that the
life-extending benefits of calorie restriction do not occur if the animal
has been genetically altered to lack sirtuins, indicating these enzymes
are crucial to this process.

Now scientists are coming to understand sirtuins' role in that
life-extending response. In people, they seem to halt the normal cellular
cycle that ends with old cells committing suicide and instead help
rejuvenate them by beefing up their DNA repair processes and stimulating
production of protective antioxidants.

"What we think is that if a cell is at a point of deciding whether to
live or die, these sirtuins push toward the survival mode and let the
cell try a little harder and longer to fix itself," said Sinclair, who
has a financial stake in a new effort to develop sirtuin-related products
with BIOMOL Research Laboratories of Plymouth Meeting, Pa.

Leonard Guarente, a researcher at the Massachusetts Institute of
Technology in Cambridge, is also enthusiastic about the compounds'
potential as anti-aging aids.

"We're very keen on the idea that this is it" -- that sirtuins are the
central regulator of the aging process -- Guarente said. He is a founder
of Elixir Pharmaceuticals of Cambridge, Mass., which, like Sinclair and
BIOMOL, hopes to capitalize on chemicals that can boost sirtuin activity.


The goal is to make drugs or nutritional supplements that can fool the
body into thinking it's living on a radically calorie-reduced diet, in
effect allowing people to eat their cake and live longer, too.

The new report from Sinclair's team is the first to show that it is
indeed possible to tweak the sirtuin pathway. The group screened a large
number of biologically active chemicals -- simple compounds that can be
made into drugs with relative ease. They found several that increase
sirtuin activity at least two-fold, including resveratrol.

When they added some of these compounds to yeast cells growing in culture
dishes, the cells produced 70 percent more daughter cells than normal --
a common measure of yeast youthfulness.

Human cells seemed to benefit, too. Those treated with sirtuin boosters
enjoyed long lives in laboratory dishes even after being exposed to
ionizing radiation, which damages DNA and usually shortens a cell's
lifespan.

And in experiments not yet completed, Sinclair said, the compounds have
shown evidence of being able to extend the life spans of two full-blown
organisms: the soil-dwelling nematode worm known as C. elegans and the
common fruit fly. Both are popular stand-ins with scientists trying to
understand human biological processes.

Sinclair said his group plans to start feeding sirtuin boosters to mice
in the next few months and then move up to testing in monkeys. The
immediate goal in people would be to slow the progression of diseases of
aging such as Alzheimer's, because a more generic slowing of the aging
process could take decades to prove.

But others warned against exaggerated expectations. Richard Weindruch, a
gerontologist and expert in calorie restriction at the University of
Wisconsin in Madison, said the work was "very interesting and deserves to
be carefully explored in mammals." But he questioned the relevance of the
yeast experiments -- which, strictly speaking, measured not life span but
the number of times a yeast cell could divide and produce daughter cells.

"Clearly, numbers of generations are related to time, but it's not the
same in my mind as following a single animal over its lifetime,"
Weindruch said. Indeed, he noted, "What they are really looking at here
is increased proliferative capacity," which he and others noted is akin
to cancer.

David Finkelstein, an expert in metabolic regulation at the National
Institute on Aging, which funded some of Sinclair's work, said the work
was "very nice science" but also warned against leaping to conclusions.
"We have results in a lower organism," he said, "and at this point,
there's a lot of hand waving because of how little we know."

Finkelstein also advised against taking the resveratrol results too
literally.

"Would the National Institute on Aging recommend you drink red wine every
day? The answer is 'no,' " he said. "If you were to add a glass of red
wine every day without changing your caloric intake, you're going to gain
weight. And we know -- we know -- that if you gain weight, that's going
to be harmful while this 'benefit' is a benefit that may or may not
occur."

"People are always looking for a quick fix," Finkelstein said. "Tell
people to eat a healthy diet."

--------

http://www.lenzwine.com/faq/faq-21-resveratrol.htm

"What is resveratrol, and is there any in my wine?"
 .  The findings from medical research, on the effects of wine
consumption, are by now fairly overwhelming: moderate consumption is
certainly very good for you. But why? In a typical study, the
relationship that may be shown between presumed cause and presumed effect
should be treated cautiously unless and until a specific mechanism can be
found that explains the link. 

 .  The beneficial effects of wine consumption come, in part, from the
alcohol itself. Most studies of the effects of alcohol consumption upon
health give similar results no matter whether the source of alcohol is
wine, whiskey or weissbier. But wine, red wine in particular, has shown
in some studies that it has an added effect. Searching for a mechanism
that might explain such a wine-linked benefit, researchers have isolated
a compound which goes by the awkward name resveratrol. 

 .  Resveratrol (sometimes called trans-resveratrol) is a phenolic
compound found in grape skins. Having isolated the compound, researchers
are able to study its effects directly. The current focus is on its role
as an anti-oxidant (it may help protect cells against the harmful effects
of naturally occurring free radicals in the body that would otherwise
cause cell damage), as a phytoestrogen (it may modulate levels of
estrogen, reducing the suspected effects of high estrogen in inducing
cancer - - especially breast cancer in women), and as a cytotoxin (it may
actively destroy cancer cells). 

 .  Wow! And we just thought wine tasted good and went well with food. 

 .  This is a very exciting research direction and it is a very active
field. New findings emerge every couple of months, yet very little seems
to make the pages of our newspapers, for some reason. 

 .  The role of resveratrol in the grape is also the subject of research.
It is supposed that it forms part of the grape�s own defense against
disease. Specifically, it is thought to be a defense against fungus
infection which particularly afflicts vinifera grape varieties, the kind
used to make most fine wines. It is seemingly present in both red and
white grapes but the different winemaking process results in far higher
concentrations in red wines than in white wines. The levels of
resveratrol that you find in a wine also differ by variety, with pinot
noir (which is notoriously susceptible to the botrytis fungus) often the
highest. Merlot also tends to be high and cabernet (which is very
thick-skinned and hardy) is much lower. 

 .  Geography matters too. Long Island wines turn out to have very high
resveratrol levels, presumably reflecting the humid summer climate that
puts the vines and the grapes under continuing fungus pressure. 

 .  We recently had Lenz merlot analyzed and found that it had the
highest level the lab had ever tested in a merlot! Enjoy! 

-------
http://www.news.cornell.edu/Chronicle/98/2.5.98/resveratrol.html


N.Y. red wines 
By Blaine P. Friedlander Jr. 
New York state red wines have higher levels of resveratrol -- a naturally
occurring substance in grapes that has been found to reduce the chance of
heart disease and cancer -- than comparable wines from other regions of
the world, according to Leroy Creasy, professor of fruit and vegetable
science. Creasy recently completed an analysis of more than 100 red wines
from five states and foreign countries. 

Although resveratrol is a compound found in some other plants, grapes and
grape products -- particularly wine -- are the most substantial sources. 

(The first study showing resveratrol's cancer preventative properties was
written by Jang, M., et al., "Cancer Chemopreventive Activity of
Resveratrol, A Natural Product Derived From Grapes," Science, January
1997. One of the early references of resveratrol's properties beneficial
to the heart include a paper written by Evan H. Siemann and Creasy,
"Concentration of the Phytoalexin Resveratrol in Wine," The American
Journal of Enology and Viticulture, Vol. 43, 1992.) 

Creasy's study, consisting mostly of 1995 vintages, included 70 New York
state red wines, 19 from California and 22 from other states or
countries. New York wines had the highest resveratrol concentration
compared with wines from other regions, he found. "Some of New York
wines, particularly in the pinot noir category, have extraordinary
levels," he said. 

Resveratrol concentration is measured in units called micromolar (�M),
and an average red wine could have 3 to 4 �M. Wines above 5 �M of
resveratrol are considered high, those above 7 are considered very high
and any product above 10 is extraordinary, Creasy said. New York wines
used for this study came from Long Island, the Hudson Valley, the Finger
Lakes and the Lake Erie regions. The California wines came from the
Central Coast, Mendocino, North Coast and Sonoma. And the other U.S.
wines came from Mississippi, Oregon and the state of Washington.
Countries represented include Argentina, Australia, Canada, Chile,
France, Italy, Slovenia and South Africa. 

The average resveratrol content of all New York wines tested was 7.5 �M,
compared with 5.8 �M for non-New York reds and 5 �M for California red
wines. 

The type of wine with by far the highest resveratrol levels was pinot
noir, with 11 of the 17 New York wines registering above 10 �M. For pinot
noir, the average levels were 13.6 �M for New York, 11 �M for all non-New
York and 10.1 �M for California. 

Variations were striking in the cabernet sauvignon category. New York
wine had an average of 8.3 �M in this category, with all non-New York
cabernet sauvignons at 3.7 �M, and California's at 1.7 �M. New York
cabernet sauvignon Francs averaged 8.6 �M, but non-New York wines were
not analyzed for comparison in this category. 

New York merlots averaged 6.5 �M compared with all non-New York merlots
at 4.7 �M and California merlots at 5.3 �M. 

New York wines also had the highest individual levels in each of these
categories, with one merlot at 10.7 �M, a cabernet sauvignon at 19.2 �M,
a pinot noir at 46.1 �M, a New York cabernet Franc at 16.9 �M and a
lemberger at 15.3 �M. 

"New York's relatively humid climate explains the higher concentrations
of resveratrol in the wines," Creasy said. "Resveratrol is a natural
fungicide, and the more humid the climate, the more is produced to combat
mildew. During the long contact between the grape skins and the juice in
producing red wines, the resveratrol is transferred into the wine." 

The importance of the wine-making process in enhancing the resveratrol
content was dramatically illustrated by Creasy's analysis of white wines
-- eight from New York and five others -- which do not involve prolonged
grape skin contact in the wine-making process and have negligible amounts
of resveratrol. The New York white wines averaged 0.58 �M and the others,
0.6 �M. 

The New York Wine and Grape Foundation, which gets matching funds from
New York state, funded Creasy's study. 

"Every year wines are bound to have different amounts of resveratrol, and
this makes it difficult for the consumer to figure out which kind of wine
has more resveratrol over another," said Creasy. "So, the consumer is
better off with a New York red than other reds, and the odds are better
that the pinot has more resveratrol than cabernet. Consumers should buy a
variety of wines, from different years and from different wineries." 

_______________________________________________
http://www.mccmedia.com/mailman/listinfo/brin-l

Reply via email to